Add-On Therapy to Risperidonein Schizophrenia

Summary

Add-On Therapy to Risperidonein Schizophrenia is a clinical trial^[1].

Key Facts

• Add-On Therapy to Risperidonein Schizophrenia is in the country of Taiwan^[2].
• Add-On Therapy to Risperidonein Schizophrenia's instance of is recorded as clinical trial^[3].
• Add-On Therapy to Risperidonein Schizophrenia's start time is recorded as +2005-01-31T00:00:00Z^[4].
• Add-On Therapy to Risperidonein Schizophrenia's end time is recorded as +2008-12-31T00:00:00Z^[5].
• Add-On Therapy to Risperidonein Schizophrenia's sponsor is recorded as National Cheng Kung University Hospital^[6].
• Add-On Therapy to Risperidonein Schizophrenia's main subject is recorded as schizophrenia^[7].
• Add-On Therapy to Risperidonein Schizophrenia's number of participants is recorded as {'unit': '1', 'amount': '+161'}^[8].
• Add-On Therapy to Risperidonein Schizophrenia's title is recorded as A Double-blind, Placebo-Controlled, Randomized Study of the Efficacy of Dextromethorphan as Add-On Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia^[9].
• Add-On Therapy to Risperidonein Schizophrenia's short name is recorded as DM^[10].
• Add-On Therapy to Risperidonein Schizophrenia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Add-On Therapy to Risperidonein Schizophrenia's ClinicalTrials.gov ID is recorded as NCT01189006^[12].
• Add-On Therapy to Risperidonein Schizophrenia's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[13].
• Add-On Therapy to Risperidonein Schizophrenia's research intervention is recorded as risperidone^[14].
• Add-On Therapy to Risperidonein Schizophrenia's clinical trial phase is recorded as phase II clinical trial^[15].
• Add-On Therapy to Risperidonein Schizophrenia's clinical trial phase is recorded as phase III clinical trial^[16].
• Add-On Therapy to Risperidonein Schizophrenia's study type is recorded as interventional study^[17].